Skip to main content
Premium Trial:

Request an Annual Quote

Solexa s Plan to Sequence Human Genome Tops Most Read GenomeWeb News Stories Last Week

NEW YORK, Dec. 19 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 16.

1.  Solexa, Releasing New Sequencer, Will Sequence Human Genome in '06 (from Dec. 13)

2.  Applera, Bio-Rad Agree to Settle PCR Infringement Suit(from Dec. 15)

3.  Applera Will Pay Undisclosed Sum to Genetic Technologies to Settle IP-Infringement Suit (from Dec. 12)

4. Roche to Invest $1.6M in Diabetes Biomarker-Discovery Research with SystemsX (from Dec. 14)

5.  Third Wave CEO Resigns, Says Firm's 'New Business Model' Represents 'Excellent Time' for New Leadership (from Dec. 15)

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more